Vitamin D and innate immunity of the skin;Vitamin D und die angeborene Immunabwehr der Haut

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 46, 2012, Pages 2385-2389

  Reinholz, M ^a   Schauber, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

antimicrobial peptides; atopic eczema; cathelicidin LL 37; inflammatory skin diseases; innate immunity; psoriasis; vitamin D

Indexed keywords

VITAMIN D;

DERMATITIS; INNATE IMMUNITY; REVIEW;

CYTOKINES; DERMATITIS; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION; SKIN; VITAMIN D;

EID: 84868335564     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1327277     Document Type: Review

References (34)

1. Ala-Houhala M. J., Vahavihu K., Hasan T. et al. Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol: 2012; 167 160 164
2. Bogh M. K., Schmedes A. V., Philipsen P. A. et al. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol: 2010; 130 546 553
3. Braf M. H., Zaiou M., Fierer J. et al. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun: 2005; 73 6771 6781 (Pubitemid 41368844)
4. Dombrowski Y., Peric M., Koglin S. et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med: 2011; 3 82ra38
5. Dorschner R. A., Pestonjamasp V. K., Tamakuwala S. et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol: 2001; 117 01 91 7 (Pubitemid 32652444)
6. EuropeanCommision Commision Directive 2008/100/EC. in The Commision of the European Communities.: 2008; 9 12
7. Gilliet M., Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol: 2008; 20 401 407
8. Harder J., Bartels J., Christophers E. et al. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem: 2001; 276 5707 5713
9. Hata T. R., Kotol P., Jackson M. et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol: 2008; 122 829 831
10. Hintzpeter B., Mensink G. B., Thierfelder W. et al. Vitamin D status and health correlates among German adults. Eur J Clin Nutr: 2008; 62 1079 1089
11. Hintzpeter B., Scheidt-Nave C., Muller M. J. et al. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr: 2008; 138 1482 1490
12. Holick M. F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc: 2006; 81 353 373 (Pubitemid 43334631)
13. Howell M. D., Wollenberg A., Gallo R. L. et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol: 2006; 117 836 841
14. Hypponen E., Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr: 2007; 85 860 868 (Pubitemid 46393520)
15. IOM Ross AC, A.L.Y, Del HB, ValleE. Dietary Reference Intakes for Calcium and Vitamin D. in Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine: 2011
16. Lanham-New S. A., Buttriss J. L., Miles L. M. et al. Proceedings of the Rank Forum on Vitamin D. Br J Nutr: 2011; 105 144 156
17. Liu P. T., Stenger S., Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science: 2006; 311 1770 1773
18. Looker A. C., Johnson C. L., Lacher D. A. et al. Vitamin d status: United States, 2001-2006. NCHS Data Brief: 2011; 1 8
19. Mallbris L., Carlen L., Wei T. et al. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Exp Dermatol: 2010; 19 442 449
20. Maruotti N., Cantatore F. P. Vitamin D and the immune system. J Rheumatol: 2010; 37 491 495
21. Murakami M., Ohtake T., Dorschner R. A. et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol: 2002; 119 1090 1095 (Pubitemid 35434172)
22. Nestle F. O., Di Meglio P., Qin J. Z. et al. Skin immune sentinels in health and disease. Nat Rev Immunol: 2009; 9 679 691
23. Ong P. Y., Ohtake T., Brandt C. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med: 2002; 347 1151 1160
24. Pasupuleti M., Schmidtchen A., Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol: 2011; 32 143 171
25. Peric M., Koglin S., Kim S. M. et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol: 2008; 181 8504 8512
26. Reinholz M., Ruzicka T., Schauber J. Vitamin D and its role in allergic disease. Clin Exp Allergy: 2011; 42 817 826
27. Ross A. C., Manson J. E., Abrams S. A. et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab: 2011; 96 53 58
28. Schauber J., Dorschner R. A., Coda A. B. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest: 2007; 117 803 811 (Pubitemid 46348539)
29. Schauber J., Gallo R. L. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol: 2008; 122 261 266
30. Schauber J., Gallo R. L. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol: 2007; 127 510 512
31. Tuohimaa P., Lou Y. R. Optimal serum calcidiol concentration for cancer prevention. Anticancer Res: 2012; 32 373 381
32. Vahavihu K., Ala-Houhala M., Peric M. et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol: 2010; 163 321 328
33. Williams H., Robertson C., Stewart A. et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol: 1999; 103 125 138 (Pubitemid 29063202)
34. Yu J., Mookherjee N., Wee K. et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol: 2007; 179 7684 7691